Development of an inhalable antiviral powder formulation against respiratory syncytial virus-Reference-Cited by-同舟云学术

Development of an inhalable antiviral powder formulation against respiratory syncytial virus

Published:2023-05 Issue: Volume:357 Page:264-273
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Heida Rick,Akkerman Renate,Jacob Silva Paulo H.,Lakerveld Anke J.,Ortiz Daniel,Bigogno Chiara,Gasbarri Matteo,van Kasteren Puck B.,Stellacci Francesco,Frijlink Henderik W.,Huckriede Anke L.W.,Hinrichs Wouter L.J.

Funder

Ministerie van Volksgezondheid, Welzijn en Sport

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference47 articles.

1. Pandemics throughout history;Piret;Front. Microbiol.,2021

2. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019;Jin;EClinicalMedicine.,2021

3. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019;Kyu;Lancet Infect. Dis.,2022

4. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022

5. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study;Wildenbeest;Lancet Respir. Med.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity;2024-07-09

2. Resveratrol inhibits respiratory syncytial virus replication by targeting heparan sulfate proteoglycans;Food & Function;2024

3. Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice;Pharmaceutics;2023-06-28